Arthritis Clinical Trials
Links shared publicly online about this topic.
- 986total visits
Arthritis Clinical Trials
View full resource at clinicalconnection.com
Tags: Arthritis, Rheumatoid Arthritis, Clinical Trial
Most Recently Shared on July 29, 2010 at 11:00 pm By:
Suffer from osteo or rheumatoid arthritis? You may be eligible to participate in a clinical trial: http://bit.ly/apcne1
NextBio Announces NextBio Clinical, Integrates Patient Genomic Data | Biomarker Commons
biomarkercommons.org — “NextBio announced today NextBio Clinical, an extension of the company’s existing life sciences platform to translational medicine applications such as biomarker discovery and clinical trial optimization. NextBio Clinical enables the application of clinical information earlier in the discovery process to enhance research and development.” View full resource at biomarkercommons.org
Most Recently Shared on April 23, 2012 at 2:43 pm By:
Study: Use of drug following first sign of possible MS reduces likelihood of progression to MS
eurekalert.org — “People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21-28, 2012.” View full resource at eurekalert.org
Most Recently Shared on April 20, 2012 at 7:17 am By:
Study: Use of drug following first sign of possible MS reduces likelihood of progression to MS: ( American Acade... http://t.co/DJO0pAcf
Revised View Enhances Provenge OS Data
onclive.com — “A further analysis of clinical trial data for sipuleucel-T suggests that it may have delivered a greater OS benefit than previously described.” View full resource at onclive.com
Most Recently Shared on April 19, 2012 at 9:28 pm By:
Revised View Enhances Provenge OS Data http://t.co/0tCNQgLP #prostatecancer
Oral Bacteria Linked to Arthritic Joint Destruction
painlive.com — “Oral bacteria may be present in the synovial fluid of patients with arthritis and could be a contributing factor to joint failure, according to a pilot study published in the April 2012 issue of the Journal of Clinical Rheumatology.” View full resource at painlive.com
Most Recently Shared on April 19, 2012 at 7:10 pm By:
Oral Bacteria Linked to Arthritic Joint Destruction http://t.co/21KNtr88
Sanofi and Michael J. Fox Foundation Collaborate on Potential New Treatment for Parkinson's... -- PARIS, April 19, 2012 /PRNewswire/ --
prnewswire.com — “Sanofi and Michael J. Fox Foundation Collaborate on Potential New Treatment for Parkinson's Disease. - Fox Foundation to sponsor a clinical trial to study Sanofi compound -.” View full resource at prnewswire.com
Most Recently Shared on April 19, 2012 at 1:15 pm By:
PR: Sanofi and Michael J. Fox Foundation Collaborate on Potential New Treatment for Parkinson's http://t.co/VR1kr3k3 via @PRNewswire
Vaccine extends life of brain cancer patients - Yahoo! News India
in.news.yahoo.com — “'Vaccine extends life of brain cancer patients' on Yahoo! News India. Washington, April 19 (IANS) A new brain cancer vaccine, which uses material from patients' own tumours, holds promise of extending their lives by several months, show results of a multicentre phase-two clinical trial of the vaccine.” View full resource at in.news.yahoo.com
Most Recently Shared on April 19, 2012 at 1:05 pm By:
Vaccine extends life of brain cancer patients: Washington, April 19 (IANS) A new brain cancer vaccine, which use... http://t.co/Ui9dfsdf
New Brain Cancer Vaccine Displays Success In Second Clinical Trial - Health News - redOrbit
redorbit.com — “On Tuesday, April 17, researchers from the University of California, San Francisco (UCSF) presented results at the American Association of Neurological Surgeons (AANS) meeting in Miami, Florida that a new brain cancer vaccine tailored to individual subjects had been successful in its second clinical trial.” View full resource at redorbit.com
Most Recently Shared on April 18, 2012 at 7:03 pm By:
New Brain Cancer Vaccine Displays Success In Second Clinical Trial: Connie K. Ho for http://t.co/nBP7sQqf On Tues... http://t.co/iwLUkdAv
Medgenics seeks IND approval to initiate EPODURE Biopump Phase IIb anemia study in ESRD patients
news-medical.net — “Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed an Investigational New Drug application with the U.S. Food and Drug Administration to initiate a Phase IIb multi-center, 100-patient clinical trial.” View full resource at news-medical.net
Most Recently Shared on April 18, 2012 at 4:01 pm By:
Diabetes News: Medgenics seeks IND approval to initiate EPODURE Biopump Phase IIb anemia study in ESRD patients:... http://t.co/ol32Ok8K
Drug May Lower Gluten Toxicity in Patients with Celiac Disease - Celiac.com
celiac.com — “Biopharmaceutical development company, BioLineRx, has announced results from pre-clinical trials which show that their compound, BL-7010, an orally available treatment for celiac disease, reduces the ...” View full resource at celiac.com
Most Recently Shared on April 18, 2012 at 9:19 am By:
Drug May Lower Gluten Toxicity in Patients with Celiac Disease - http://t.co/2y1rcrPk http://t.co/r31MN96a #GF #Celiac
Idera commences IMO-3100 Phase 2 clinical trial for psoriasis
news-medical.net — “Idera Pharmaceuticals, Inc. today announced the treatment of the first patient in a Phase 2 clinical trial of IMO-3100, the Company's lead Toll-like receptor (TLR) inhibitor for the treatment of autoimmune diseases, in patients with moderate to severe plaque psoriasis.” View full resource at news-medical.net
Most Recently Shared on April 18, 2012 at 6:26 am By:
Idera commences IMO-3100 Phase 2 clinical trial for psoriasis: Idera Pharmaceuticals, Inc. today announced the t... http://t.co/wEfJcG0T
Pharmaxis asthma treatment found safe, but is it effective? - Pharmaxis, immunology, Drug Development, clinical trials, Biotechnology, asthma - Australian Life Scientist
lifescientist.com.au — “A phase IIa trial of Pharmaxis’ (ASX:PXS) experimental allergic asthma drug, ASM8, has been shown safe, but more trials will be required to demonstrate efficacy.” View full resource at lifescientist.com.au
Most Recently Shared on April 17, 2012 at 7:08 pm By:
Pharmaxis asthma treatment found safe, but is it effective? - http://t.co/afcJp0X8
ASCO University Sign In
asco.org — “ASCO University Sign In” View full resource at asco.org
Most Recently Shared on April 17, 2012 at 7:01 pm By:
26 yo w/ stage IV melanoma, metast to liver, lungs, skin. Treatment? Download the Focus Under Forty: Melanoma slides http://t.co/VJXzokOI
Shot Delivers Scant Relief for Back Pain (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- Epidural injections provided modest short-term pain relief from lumbrosacral radiculopathy, whether used with steroids or an anti-inflammatory biologic agent, a clinical trial showed.” View full resource at qualitypointtech.net
Most Recently Shared on April 17, 2012 at 5:45 pm By:
Shot Delivers Scant Relief for Back Pain (CME/CE): (MedPage Today) -- Epidural injections provided modest short-te... http://t.co/maY4gt8n
Pilot Study 1 of Outpatient Control-to-Range - System and Monitoring Testing - Full Text View - ClinicalTrials.gov
clinicaltrials.gov — “Pilot Study 1 of Outpatient Control-to-Range - System and Monitoring Testing - Full Text View - ClinicalTrials.gov” View full resource at clinicaltrials.gov
Most Recently Shared on April 17, 2012 at 5:32 pm By:
Pilot Study 1 of Outpatient Control-to-Range - System and Monitoring Testing http://t.co/bhrtpYpP cool hotel room and a cell phone #cure
Cimzia Trial Shows Promise For Axial Spondyloarthritis And Ankylosing Spondylitis
medicalnewstoday.com — “According to UCB, certolizumab pegol achieved top-level results in a phase 3 study, which assessed the drug's efficacy and safety in patients with adult-onset active axial spondyloarthr” View full resource at medicalnewstoday.com
Most Recently Shared on April 17, 2012 at 5:05 pm By:
Cimzia Trial Shows Promise For Axial Spondyloarthritis And Ankylosing Spondylitis http://t.co/o6piItx0 #healthnews
Advertisement

